Overall rank by patents
#23,119
of 50,000 tracked assignees
USPTO PatentsView assignee record - 12 granted patents across 4 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: E04C (STRUCTURAL ELEMENTS; BUILDING MATERIALS).
The verdict
According to USPTO PatentsView, OCM ranks #23,119 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 4 technology areas.
USPTO PatentsView assignee plate
Corpus R23119 · US Corporation #23,119 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Numab Therapeutics Ag (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
American Vehicular S… · near
38 score
Id me · near
38 score
OCM · this assignee
38 score
Rexnord Flattop Euro… · near
38 score
Think Laboratory · near
38 score
3D Lighting Innovati… · lowest
7 score
What this shows OCM's Innovation Score is 37.8/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
OCM Inc. is a focused PatentsView assignee: 4 CPC subclasses with 25% of grants classified under E04C (STRUCTURAL ELEMENTS; BUILDING MATERIALS). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2019. By volume, OCM sits between Numab Therapeutics Ag and ONE Concern, Inc..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Numab Therapeutics AG
12 patents
Nura Holdings Pty Ltd
12 patents
Nxera Pharma UK Limited
12 patents
OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU “WELDUP”
12 patents
OFFICINE MACCAFERRI S.P.A.
12 patents
OLEON NV
12 patents
OMNIMAX INTERNATIONAL, LLC
12 patents
ONE CONCERN, INC.
12 patents
OCM Inc.
12 patents
What this shows OCM holds 12 patents at rank #23,111, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #23,111 in granted patent volume.
Other assignees with the most granted patents in OCM's primary technology class.
Two PlainPatent-derived peer sets for OCM, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (38 here).
OCM's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
38 Top 43% higher than 57% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 8.3% |
| 2020 | 2 | 16.7% |
| 2022 | 2 | 16.7% |
| 2023 | 3 | 25.0% |
| 2024 | 3 | 25.0% |
| 2025partial year | 1 | 8.3% |
Top 4 of 4 technology areas
Overall rank by patents
#23,119
of 50,000 tracked assignees
37.8 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.